MDT

89.46

+0.89%↑

VEEV

281.37

+0.23%↑

A

113.33

-1.71%↓

WBA

11.49

-0.09%↓

HQY

97.29

-0.38%↓

MDT

89.46

+0.89%↑

VEEV

281.37

+0.23%↑

A

113.33

-1.71%↓

WBA

11.49

-0.09%↓

HQY

97.29

-0.38%↓

MDT

89.46

+0.89%↑

VEEV

281.37

+0.23%↑

A

113.33

-1.71%↓

WBA

11.49

-0.09%↓

HQY

97.29

-0.38%↓

MDT

89.46

+0.89%↑

VEEV

281.37

+0.23%↑

A

113.33

-1.71%↓

WBA

11.49

-0.09%↓

HQY

97.29

-0.38%↓

MDT

89.46

+0.89%↑

VEEV

281.37

+0.23%↑

A

113.33

-1.71%↓

WBA

11.49

-0.09%↓

HQY

97.29

-0.38%↓

Search

BioCryst Pharmaceuticals Inc

Closed

SectorHealthcare

8.72 -2.68

Overview

Share price change

24h

Current

Min

8.7

Max

8.97

Key metrics

By Trading Economics

Income

27M

32K

Sales

14M

146M

Profit margin

0.022

Employees

580

EBITDA

22M

21M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+86.94% upside

Dividends

By Dow Jones

Next Earnings

4 sie 2025

Market Stats

By TradingEconomics

Market Cap

23M

1.9B

Previous open

11.4

Previous close

8.72

News Sentiment

By Acuity

50%

50%

154 / 376 Ranking in Healthcare

BioCryst Pharmaceuticals Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

15 lip 2025, 23:41 UTC

Market Talk

Nikkei May Trade in Range Amid Tariff Uncertainty -- Market Talk

15 lip 2025, 23:40 UTC

Market Talk

Gold Edges Higher on Possible Position Adjustments -- Market Talk

15 lip 2025, 23:05 UTC

Market Talk

Auckland International Airport Passenger Growth May Disappoint Again -- Market Talk

15 lip 2025, 21:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 lip 2025, 21:36 UTC

Market Talk

Canada CPI Data Fuel Rate-Prediction Revisions -- Market Talk

15 lip 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

15 lip 2025, 20:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

15 lip 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15 lip 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

15 lip 2025, 20:14 UTC

Acquisitions, Mergers, Takeovers

Chinese EV Makers to Combine. Geely Is Buying Zeekr. -- Barrons.com

15 lip 2025, 20:07 UTC

Earnings

BlackRock Shares Tumble After Big Client Redemption Blunts Quarterly Results -- Update

15 lip 2025, 20:06 UTC

Market Talk

Nvidia, AMD Seen Benefiting from Return to Chinese Chip Sales -- Market Talk

15 lip 2025, 19:54 UTC

Market Talk

Global Equities Roundup: Market Talk

15 lip 2025, 19:54 UTC

Market Talk

Meta CEO Hints at Higher Revenues, Expenses With Data Center Plans -- Market Talk

15 lip 2025, 19:38 UTC

Market Talk

Oil Falls As Eventual Oversupply Concerns Weigh -- Market Talk

15 lip 2025, 19:09 UTC

Market Talk

U.S. Natural Gas Futures Post Back-to-Back Gains -- Market Talk

15 lip 2025, 19:07 UTC

Market Talk

Canada CFOs Willing to Take Risks, Increase Spending -- Market Talk

15 lip 2025, 19:03 UTC

Market Talk

Gold Slips as Big Buyers Pull Back -- Market Talk

15 lip 2025, 18:32 UTC

Acquisitions, Mergers, Takeovers

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15 lip 2025, 18:31 UTC

Acquisitions, Mergers, Takeovers

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

15 lip 2025, 18:13 UTC

Market Talk

Canada Adopts 'Note of Realism' in US Trade Talks, Setting Stage for Possible Tariff Deal -- Market Talk

15 lip 2025, 17:40 UTC

Market Talk

Canadian Inflation Adds to Case for Bank of Canada Extending Pause -- Market Talk

15 lip 2025, 17:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 lip 2025, 17:25 UTC

Acquisitions, Mergers, Takeovers

National Fuel Gas Gets Rare Double Upgrade. Buy the Stock, Analyst Says. -- Barrons.com

15 lip 2025, 17:24 UTC

Market Talk

Dollar Gains Strength After Inflation Data -- Market Talk

15 lip 2025, 16:49 UTC

Market Talk

Oil Futures Likely to Continue Sideways Trade -- Market Talk

15 lip 2025, 16:20 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

15 lip 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15 lip 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

15 lip 2025, 15:42 UTC

Market Talk

Coca-Cola Seen as Top Pick Ahead of Consumer Staples Earnings -- Market Talk

Peer Comparison

Price change

BioCryst Pharmaceuticals Inc Forecast

Price Target

By TipRanks

86.94% upside

12 Months Forecast

Average 16.75 USD  86.94%

High 30 USD

Low 11 USD

Based on 12 Wall Street analysts offering 12 month price targets forBioCryst Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

11

Buy

1

Hold

0

Sell

Sentiment

By Acuity

154 / 376 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX10013, an oral factor D inhibitor for complement-mediated diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.